NCT00001582View on ClinicalTrials.gov

Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer

CompletedOBSERVATIONAL

Enrollment

902

Participants

Timeline

Start Date

June 7, 1997

Primary Completion Date

March 17, 2023

Study Completion Date

March 17, 2023

Conditions

T-cell LymphomaB-Cell LymphomaATLMyeloma

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH